Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
2.480
+0.140 (5.98%)
At close: Jan 7, 2026, 4:00 PM EST
2.370
-0.110 (-4.44%)
After-hours: Jan 7, 2026, 7:56 PM EST
Cibus Market Cap
Cibus has a market cap or net worth of $134.62 million as of January 7, 2026. Its market cap has increased by 35.84% in one year.
Market Cap
134.62M
Enterprise Value
370.20M
1-Year Change
35.84%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $288.70M to $134.62M, a decrease of -53.37%. That is a compound annual growth rate of -8.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 127.00M | 34.39% |
| Dec 31, 2025 | 94.50M | 14.96% |
| Dec 31, 2024 | 82.20M | -80.39% |
| Dec 29, 2023 | 419.20M | 5,722.22% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.00M | -47.57% |
| Dec 31, 2020 | 156.40M | -32.29% |
| Dec 31, 2019 | 231.00M | -31.54% |
| Dec 31, 2018 | 337.40M | -44.70% |
| Dec 29, 2017 | 610.10M | 111.33% |
| Jul 20, 2017 | 288.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |